Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53.2Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-57.4
Enterprise Value $M63.5EPS (TTM) $-0.3Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-5.8Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-23.4Quick Ratio0.8Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-6.8Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-171.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,466.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M85.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PTN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PTNFirst Eagle Investment 2013-06-30 Sold Out -0.0002%$0.58 - $0.67
($0.61)
$ 0.622%Sold Out0
PTNFirst Eagle Investment 2013-03-31 Reduce$0.551 - $0.68
($0.62)
$ 0.620%Reduce -84.35%121,094
PTNFirst Eagle Investment 2012-09-30 Reduce$0.48 - $0.75
($0.66)
$ 0.62-6%Reduce -53.47%773,660
PTNFirst Eagle Investment 2011-12-31 Add$0.4019 - $0.6789
($0.55)
$ 0.6213%Add 72.72%1,662,543
PTNFirst Eagle Investment 2011-09-30 Add$0.5032 - $1.14
($0.84)
$ 0.62-26%Add 35.10%962,543
PTNFirst Eagle Investment 2011-06-30 Reduce-0.01%$0.82 - $1.08
($0.9)
$ 0.62-31%Reduce -54.36%712,443
PTNFirst Eagle Investment 2011-03-31 Add0.01%$0.8 - $1.4
($1.09)
$ 0.62-43%Add 1441.78%1,560,895
PTNFirst Eagle Investment 2010-06-30 Reduce$1.8 - $3.2
($2.65)
$ 0.62-77%Reduce -24.39%114,967
PTNKen Fisher 2010-06-30 Sold Out $1.8 - $3.2
($2.65)
$ 0.62-77%Sold Out0
PTNFirst Eagle Investment 2009-12-31 Reduce$2.4 - $3.9
($3.05)
$ 0.62-80%Reduce -8.98%152,062
PTNFirst Eagle Investment 2009-09-30 Reduce$2.2 - $3.8
($3.05)
$ 0.62-80%Reduce -44.74%167,062
PTNFirst Eagle Investment 2009-06-30 Reduce$1.1 - $3.5
($2.1)
$ 0.62-70%Reduce -15.24%302,309
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PTN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PTN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hull Joseph StanleyDirector 2015-12-04Buy2,500$0.66-6.06view
Hull Joseph StanleyDirector 2015-11-19Buy2,000$0.65-4.62view
DEVEER ROBERT K JRDirector 2015-10-02Buy10,000$0.82-24.39view
BVF PARTNERS L P/IL10% Owner 2014-02-27Sell293,825$1.09-43.12view
BVF PARTNERS L P/IL10% Owner 2014-02-26Sell540,181$1.14-45.61view
BVF PARTNERS L P/IL10% Owner 2014-02-19Sell305,966$1.17-47.01view
DUNTON ALAN WDirector 2013-03-19Buy1,000$0.586.9view
DUNTON ALAN WDirector 2013-02-01Buy2,000$0.595.08view
TABER ROBERT IDirector 2013-01-28Buy5,000$0.595.08view
SPANA CARLPresident & CEO 2012-12-31Buy10,000$0.578.77view

Quarterly/Annual Reports about PTN:

News about PTN:

Articles On GuruFocus.com
Chuck Royce Cuts Second Largest Communications Equipement Holding Jul 07 2015 

More From Other Websites
Palatin Technologies' (PTN) Shares March Higher, Can It Continue? Sep 27 2016
3 Reasons Why Palatin Technologies (PTN) is a Great Momentum Stock Sep 26 2016
Post Earnings Coverage as Palatin Reports Q4 FY16 Results and Provides Update on Key Drugs in... Sep 26 2016
Palatin Technologies Receives Audit Opinion with Going Concern Explanation Sep 23 2016
Palatin Technologies Receives Audit Opinion with Going Concern Explanation Sep 23 2016
PALATIN TECHNOLOGIES INC Financials Sep 23 2016
Palatin Technologies Presents Bremelanotide Neurobiology and Treatment Efficacy Review at World... Sep 23 2016
Edited Transcript of PTN earnings conference call or presentation 20-Sep-16 3:00pm GMT Sep 20 2016
PALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition Sep 20 2016
Palatin Technologies, Inc. Reports Fourth Quarter And Fiscal Year 2016 Results Sep 20 2016
Palatin Technologies, Inc. Reports Fourth Quarter And Fiscal Year 2016 Results Sep 20 2016
Palatin Technologies, Inc. to Report Fourth Quarter Fiscal Year End 2016 Results; Teleconference and... Sep 14 2016
Palatin Technologies, Inc. to Report Fourth Quarter Fiscal Year End 2016 Results; Teleconference and... Sep 14 2016
Key FDA Decisions and Trial Results Expected in October Sep 08 2016
Palatin Technologies to Present at the 36th Annual Canaccord Genuity Growth Conference Aug 08 2016
Palatin Technologies Announces Closing of $9.2 Million Financing Aug 04 2016
Palatin Technologies Announces Closing of $9.2 Million Financing Aug 04 2016
Palatin Technologies Announces Completion of All Patient Visits In Phase 3 Clinical Trials of... Aug 04 2016
Palatin Technologies Announces Completion of All Patient Visits In Phase 3 Clinical Trials of... Aug 04 2016
PALATIN TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Aug 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)